Inhibition of Ankyrin-B Expression Reduces Growth and Invasion of Human Pancreatic Ductal Adenocarcinoma

Publisher： Karger

E-ISSN： 1424-3911|10|5|586-596

ISSN： 1424-3903

Source： Pancreatology, Vol.10, Iss.5, 2010-10, pp. : 586-596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A and B Blood Group Antigens in Human Pancreatic Ductal Adenocarcinomas

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 141-149

Karger

Access to resources Recommend Favorite

Evaluation of Topoisomerase IIa Expression in Pancreatic Ductal Adenocarcinoma: A Pilot Study Using Chromogenic in situ Hybridization and Immunohistochemistry on Tissue Microarrays

By  

Pancreatology, Vol. 7, Iss. 1, 2007-04 ,pp. : 45-52

Karger

Access to resources Recommend Favorite

Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies

By  

HISTOPATHOLOGY, Vol. 66, Iss. 3, 2015-02 ,pp. : 457-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of Heterozygosity Status of D9S105 Marker Is Associated with Downregulation of Krüppel-Like Factor 4 Expression in Pancreatic Ductal Adenocarcinoma and Pancreatic Intraepithelial Lesions

By  

Pancreatology, Vol. 11, Iss. 1, 2011-03 ,pp. : 30-42

Karger

Access to resources Recommend Favorite

Update on the Molecular Pathogenesis of Pancreatic Tumors Other than Common Ductal Adenocarcinoma

By  

Pancreatology, Vol. 9, Iss. 1-2, 2008-12 ,pp. : 25-33

Karger

Access to resources Recommend Favorite